Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Melissa Cheu
Observed names:
M Cheu,
M. Cheu
Institution:
Genentech
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Genentech,
University of Colorado Health,
University of Pennsylvania
ORCID:
0000-0002-1573-1194
Observed ORCID:
0000-0002-1573-1194
OpenAlex ID:
A5080144898
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
2015
·
Nicola A Hanania
, Michael Noonan
, et al.
·
Thorax
·
381
Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material
2016
·
Saloumeh Kadkhodayan Fischer
, Melissa Cheu
, et al.
·
The AAPS Journal
·
116
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect
2019
·
D.M. Chen
, A. Odueyungbo
, et al.
·
British Journal of Dermatology
·
99
PDF
Use of Quantitative Pharmacology in the Development of HAE1, a High-Affinity Anti-IgE Monoclonal Antibody
2008
·
Wendy S. Putnam
, Jing Li
, et al.
·
The AAPS Journal
·
45
PDF
A Preclinical Population Pharmacokinetic Model for Anti‐CD20/CD3 T‐Cell‐Dependent Bispecific Antibodies
2018
·
Gregory Z. Ferl
, Arthur Reyes
, et al.
·
Clinical and Translational Science
·
35
PDF
Apo2L/TRAIL pharmacokinetics in a phase 1a trial in advanced cancer and lymphoma
2006
·
J. Ling
, R. S. Herbst
, et al.
·
Journal of Clinical Oncology
·
35
Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis
2016
·
John R. Mills
, Divi Cornec
, et al.
·
Analytical Chemistry
·
34
PDF
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
2017
·
Divi Cornec
, Brian F Kabat
, et al.
·
Lara D. Veeken
·
32
PDF
Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey
2016
·
Christina L Zuch de Zafra
, Avi Ashkenazi
, et al.
·
Cell Death and Disease
·
21
PDF
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies
2022
·
Rajbharan Yadav
, Siddharth Sukumaran
, et al.
·
Pharmaceutics
·
12
PDF
Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy
2013
·
Dana L. Baker
, Kun Peng
, et al.
·
Current Medical Research and Opinion
·
10
Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis
2022
·
Candice Jamois
, Leonid Gibiansky
, et al.
·
Clinical and Translational Science
·
9
PDF
Fit-For-Purpose Biomarker Immunoassay Qualification and Validation: Three Case Studies
2016
·
Kyra Cowan
, Xiaoying Gao
, et al.
·
Bioanalysis
·
9
The Development and Characterization of a Highly Sensitive Mature TGFβ3 Assay to Evaluate Anti-TGFβ3 Target Engagement
2023
·
A. Francesca Setiadi
, Gizette Sperinde
, et al.
·
The AAPS Journal
·
4
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps
2021
·
Rui Zhu
, Ryan Owen
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
4
PDF
Response to Becher and Strohner comment regarding Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. CMRO 2014;30:913-22
2014
·
Dana L. Baker
, Kun Peng
, et al.
·
Current Medical Research and Opinion
·
4
PDF
Successful Development of Nonclinical Anti-Drug Antibody Assays to Support Zinpentraxin Alfa Reproductive Toxicology Studies
2024
·
Audrey Arjomandi
, Ketevan Siradze
, et al.
·
The AAPS Journal
·
3
OP0320 Determinants of rituximab pharmacokinetics and clinical outcomes in patients with anca-associated vasculitis
2017
·
D Cornec
, B Kabat
, et al.
·
Annals of the Rheumatic Diseases
PDF
OP0058 Using Mass Spectrometry To Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in Anca-Associated Vasculitis
2016
·
D. Cornec
, J.R. Mills
, et al.
·
Annals of the Rheumatic Diseases
Anti-Factor D Fab: In vivo Effects Following Intravitreous Administration to Cynomolgus Monkeys
2011
·
Vladimir Bantseev
, Rebecca Erickson
, et al.
·
Investigative Ophthalmology & Visual Science
Increasing Productivity Through a Combination of Automation and Robotics: A Case Study of Assay Services
2001
·
Melissa Cheu
, Laurie Myers
·
JALA Journal of the Association for Laboratory Automation
PDF
Show more works
View as search
Works count:
21
Citation count:
853
H-index:
10
I10-index:
11
Year
Topic
Type